These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 12325104

  • 1. Economic evaluation in long-term clinical trials.
    Hlatky MA, Boothroyd DB, Johnstone IM.
    Stat Med; 2002 Oct 15; 21(19):2879-88. PubMed ID: 12325104
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness as an outcome in randomized clinical trials.
    Hlatky MA, Owens DK, Sanders GD.
    Clin Trials; 2006 Oct 15; 3(6):543-51. PubMed ID: 17170039
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial.
    Weintraub WS, Barnett P, Chen S, Hartigan P, Casperson P, O'Rourke R, Boden WE, Lewis C, Veledar E, Becker E, Culler S, Kolm P, Mahoney EM, Dunbar SB, Deaton C, O'Brien B, Goeree R, Blackhouse G, Nease R, Spertus J, Kaufman S, Teo K.
    Am Heart J; 2006 Jun 15; 151(6):1180-5. PubMed ID: 16781215
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD, Rattinger GB, Kuznik A, Koren MJ.
    Clin Ther; 2008 Jun 15; 30 Pt 2():2204-16. PubMed ID: 19281915
    [Abstract] [Full Text] [Related]

  • 9. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.
    Hlatky MA, Melsop KA, Boothroyd DB, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Investigators.
    Am J Cardiol; 2006 Jun 19; 97(12A):59G-65G. PubMed ID: 16813739
    [Abstract] [Full Text] [Related]

  • 10. Comparative economic analyses of minimally invasive direct coronary artery bypass surgery.
    Gray DT, Veenstra DL.
    J Thorac Cardiovasc Surg; 2003 Mar 19; 125(3):618-24. PubMed ID: 12658204
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
    Cohen DJ, Murphy SA, Baim DS, Lavelle TA, Berezin RH, Cutlip DE, Ho KK, Kuntz RE, SAFER Trial Investigators.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1801-8. PubMed ID: 15519010
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
    Lindgren P, Stenestrand U, Malmberg K, Jönsson B.
    Clin Ther; 2005 Jan 02; 27(1):100-10. PubMed ID: 15763611
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness analysis in pathology.
    Raab SS.
    Clin Lab Med; 1999 Dec 02; 19(4):757-71, v-vi. PubMed ID: 10572713
    [Abstract] [Full Text] [Related]

  • 17. Costing and cost analysis in randomized controlled trials: caveat emptor.
    Polsky D, Glick H.
    Pharmacoeconomics; 2009 Dec 02; 27(3):179-88. PubMed ID: 19354338
    [Abstract] [Full Text] [Related]

  • 18. Clinical long-term studies: data collection and assessment.
    Boehncke WH.
    J Dtsch Dermatol Ges; 2011 Jun 02; 9(6):479-84; quiz 485. PubMed ID: 21609401
    [Abstract] [Full Text] [Related]

  • 19. Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations.
    Dakin H, Gray A.
    Stat Med; 2017 Aug 15; 36(18):2814-2830. PubMed ID: 28470760
    [Abstract] [Full Text] [Related]

  • 20. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Role of economic models in randomized clinical trials.
    Hlatky MA.
    Am Heart J; 1999 May 15; 137(5):S41-6. PubMed ID: 10220595
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.